Authors Posts by Head Editor

Head Editor


0 671

Indie Growers Association Provides Industry Update and Announces Letter of Intent

CARSON CITY, NEVADA–(Marketwired – Dec 16, 2014) – Indie Growers Association (UPOT) continues to build out its business of leasing land, greenhouses and warehouse space to licensed growers in the legal marijuana business. The Company believes that the industry is poised for exponential growth.

A Wall Street Journal article published earlier this year stated that leasing to marijuana producers is a “growth” industry because of the “… difficulties legal marijuana entrepreneurs face when trying to find space.” A Denver Post article published around the same time supports this evaluation of the industry, noting that marijuana growing space in Denver is in very short supply.

The Company has first-hand experience with the demand for suitable growing space as its wholly owned operating subsidiary, River Ridge Sunshine Farms LLC, has recently signed yet another Letter of Intent to lease a parcel at its Prosser, Washington property. Dennis Boyle, a licensed medical grower from Walla Walla, intends for his company, Curative LLC, to sign a definitive lease agreement for a 10 year renewable lease of farm land and supporting infrastructure from River Ridge Sunshine Farms.

Each tenant on the property will generate approximately $200,000 per month in lease payments. With one tenant already under lease and 3 potential tenants under a Letter of Intent, the company could generate annual income of over 9 Million dollars if their licensees are approved and production begins.

In order to facilitate the demand for growing space, the Company plans to immediately raise $2 million in a private placement so it can begin construction as quickly as possible for those who have already stated their intent to lease land and buildings from River Ridge Sunshine Farms. It intends to raise another $15 million for construction over the long term to attract more growers to the property. With 14 parcels, all of which can accommodate at least one Tier 3 grower, the revenue potential is over $30 Million per year, and even higher if more than one grower can be accommodated on each parcel.

The Company will keep shareholders updated as new developments arise.

About River Ridge Sunshine Farms LLC

River Ridge Sunshine Farms LLC is a wholly owned subsidiary of Indie Growers Association. It holds a 10 year, renewable lease on a 14 parcel agricultural property in Prosser, Washington. One of the parcels has already been subleased to a licensed medical marijuana grower who is awaiting final approval of its Tier 3 license. Three additional parcels have now been reserved by other growers under Letters of Intent. River Ridge Sunshine Farms LLC intends to sublease all of the parcels to licensed marijuana growers.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including the Company’s beliefs about its business prospects and future results of operations. Some factors that could cause actual results to differ materially include economic and operational risks, changes in anticipated earnings, continuation of current contracts, and other factors detailed in the Company’s filings with the Securities and Exchange Commission, including its most recent Forms 10-K and 10-Q. The Company forecasts provided above are dynamic and therefore refer only to this release date. The Company does not undertake to update any forecasts that it may make available to the investing public. This news release has been issued by the Company as required by law and per the Company’s listing and reporting obligations.

Indie Growers Association Inc.

Robert Coleridge, President

Indie Growers Association Inc.
1 (888) 648 0488
1 (206) 400 7569

0 1314

Tauriga Sciences Inc. CBD (Cannabidiol) Infused TopiCanna Products Have Been Officially Launched

Los Angeles, CA / ACCESSWIRE / December 16, 2014 / Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today launched its first proprietary topical medicinal cannabis cream branded as TopiCanna. TopiCanna contains cannabidiol (CBD) oil from non-GMO industrial hemp that is grown without pesticides, herbicides, or chemical fertilizers. The oil has been lab tested for quality and is natural, safe and legal in the United States and in Japan, where Tauriga has a recently announced MOU with Tokyo-based iFLOW Ltd. There are no psychoactive effects associated with the CBD oil. Tauriga previously announced on November 25, 2014 that the Company planned to launch its TopiCanna product line within the next 60 days. TopiCanna’s launch occurred well within the projected timeline. Initially the TopiCanna Products be sold directly by Tauriga Sciences, Inc. (interested parties may email inquiries to The Company plans to expand TopiCanna’s sales and marketing efforts to include online sales and distribution agreements, both domestically and internationally.

Many people who have used topical cannabis creams have reported decreased musculoskeletal pain. As such, the Company’s first TopiCanna product is designed to provide potential wellness and healing properties without narcotic effects. In addition to the CBD oil from non-GMO industrial hemp, the lotion contains ingredients for soothing dry skin.

Tauriga is also currently producing its first run of CannaCaviar soft gels using high-CBD, low-THC oil that has been extracted from the stalk of the cannabis plant. CannaCaviar is included in the recently announced MOU with iFLOW Ltd. The Company anticipates launching CannaCaviar before the end of the calendar year.

In addition to the progress on Tauriga’s CBD-containing products for the US and Japan, the Company would like to provide an update on other efforts. Tauriga is pleased to announce that the Company launched its new corporate website ( last week. The new site has provides more extensive content and has links to the company’s Facebook and Twitter pages for information that does not rise to the level of a press release. Tauriga is also on target for launching its e-commerce website e-commerce website ( later this month to sell its non-cannabis containing line of natural wellness dietary supplements. These natural supplements include IndiCalm, natural calming formula without inducing cognitive impairment; ClearNaze, a natural decongestant without stimulant or drowsiness effects; Satietiva, an amino acid-based appetite suppressant; and EndoCannabinoid Omega-3 Support (or MendOCan), a highly pure, potent and palatable Omega 3 supplement. Interested customers will be able to purchase these cannabis-free products online when the site is launched before the end of the year.

Tauriga’s Chairman & CEO Dr. Stella Sung commented, “We are proud of our efforts in building a revenue-generating company in natural wellness and cleantech, and we appreciate our shareholders for sharing our vision and our commitment.”

About Tauriga Sciences, Inc.

Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a balanced portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company’s corporate website at


Forward-Looking Statements: Except for statements of historical fact, this news release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on the Company’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which the Company has little or no control. Such forward-looking statements are made only as of the date of this release, and the Company assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by the Company with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.

Food and Drug Administration Disclaimer: None of the statements contained in this press release regarding any of the products either offered or to be offered in the future by the Company have been evaluated by the Food and Drug Administration. Additionally, none of the products is intended to diagnose, treat, cure, or prevent any disease.


Tauriga Sciences, Inc.:
Dr. Stella M. Sung,
Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
San Diego: + 1-858-353-5749
Montreal: + 1-514-840-3697

SOURCE: Tauriga Sciences, Inc.

0 1342



Change in Directors or Principal Officers

ITEM 5.02 Resignation of Director and Officer; Appointment of Officer.Effective December 9, 2014, Cathryn J. Kennedy joined the Registrant (hereinafter the “Company”) as its new Chief Financial Officer.

From 2013 to the present Ms. Kennedy served as controller and secretary to the board of directors of American Optical Services. American Optical Services owns and operates ophthalmology and optometry practices across the U.S. As controller, she managed P&L, cash flow, implemented audit policies and managed financial reporting and tax return preparation with a national firm. She managed a department of twenty five employees including personnel in the accounting and treasury departments.

From 2008 through 2013, Ms. Kennedy worked for eCommLink, Inc. eCommLink, Inc. is a prepaid card processor which supports a full array of global and domestic payments and transactions, which was sold via asset sale to Green Dot. From 2011 to 2013 she served as CFO, from 2010 to 2011 she served as Vice President of Finance and as controller from 2008 to 2010.

From 2005 to 2008, Ms. Kennedy served as director of SEC reporting for Pinnacle Entertainment Inc., an entertainment company with 15 hotel and gaming operations located in the U.S.

Prior to 2005, she served as controller for American Wagering Inc. overseeing all corporate reporting, consolidations, financial preparations, preparation of SEC reports on forms 10QSB and 10KSB, and preparation of NGC tax filings, and oversaw gaming audits and compliance.

- 2 -

ITEM 9.01 Exhibits.

Attached as Exhibit 99 is a copy of the press release announcing the appointment of Cathryn J. Kennedy as the new CFO of the Company


1 1397

Hemp, Inc. to Sponsor 1st Annual Ascent Expo in Los Angeles, CA for the “Cultural Creatives”

LAS VEGAS, Dec. 16, 2014 (GLOBE NEWSWIRE) — Hemp, Inc. (HEMP) announced today that it is one of the major sponsors of the 1st Annual “Cultural Creatives” Ascent Expo in Los Angeles, CA, February 27 — March 1, 2015 which will be held at the Los Angeles Convention Center. By assembling “Cultural Creatives” from the entertainment industry, corporate America, and mainstream media, the Ascent Expo‘s mission is to “enjoy, learn, co-create successful ventures, cooperate in facilitating commerce, and empower each other toward a higher consciousness in solving the planet’s most important social, environmental and human rights issues.”

“Hemp, Inc. is proud to continue our commitment to corporate consciousness, environmentalism, philanthropy and personal empowerment through our sponsorship of the 2015 Ascent Expo,” says Bruce Perlowin, CEO of Hemp, Inc. “This is the 1st Annual Ascent Expo and we anticipate many new innovative products and successful joint ventures. The Industrial Hemp and Medical Marijuana industries are definitely one of the subsets of the ‘Cultural Creatives’ movement which we will be showcasing in the ‘Hemp Zone’ at the Expo.”

According to executives with eWorld Companies, Inc. (EWRC), “The Ascent Expo will be an extravagant 3-day event of ‘Cultural Creatives’ showcasing cutting-edge, forward-thinking companies, individuals and non-profit organizations committed to the principles of positive psychology and applying these principles into everyday lives and activities, with a wide range of premium products and services.” eWorld Companies, Inc. (EWRC), the producer of the event, expects this “meeting of the creative minds” event to draw in over 400 exhibitors… with a 40-ft red carpet for interviews. The centerstage for A-list musical talent is expected to draw in thousands alone.

The extravagant event for Cultural Creatives‘ (also known as the country’s “forward-thinkers” and innovators who are globally aware, very green conscious and empowered philanthropists) primary goal is to help other business people. According to Ashkan Tabibnia, the event’s social media manager, powerful marketing strategies have been implemented to bring in tens of thousands of attendees. The expo is expected to attract over 20,000 professionals and over 400 exhibiting companies covering over 140,000 net square feet of exhibit space in the LA Convention Center.

Hemp, Inc., as one of the major sponsors, will function as the umbrella organization for theIndustrial Hemp and Medical Marijuana Consulting Company (IHMMCC) affiliates which include Dewmar International (DEWM), Liberated Energy (LIBE), Resource Ventures (REVI), Global Links (GLCO), VaporBrands International (VAPR), National Scientific Corp. (NSCT), and PPJ Enterprise (PPJE). North Cal Wood Products, Inc., purveyors of sustainable reclaimed lumber, will also be in attendance.

According to Perlowin, he plans to use the Ascent Expo to not only support the activities of these affiliates but to also initiate an exchange of ideas to form effective business relationships between and among both their own affiliates and other like-minded companies and organizations that will be in the Ascent Expo section dedicated to the new Industrial Hemp and Medical Marijuana industries.

The “Hemp Zone” will include, but will not be limited to, those mentioned above. As a major sponsor, Hemp, Inc. (HEMP) will also play a key role in the marketing and promotional activities leading up to the Ascent Expo including webinars and think tanks throughout the course of the event.

Perlowin will also highlight recent news and updates on Hemp, Inc.’s decortication plant in the “Hemp Zone” during the Ascent Expo. “Cultural Creatives” will get a chance to learn first-hand about the automated Temafa decortication line which will be used to process raw hemp and kenaf for the American farmers. The facility in Spring Hope, North Carolina that houses the commercial Temafa decortication line is the only one of its scale in North America.

The highly coveted commerical equipment would, according to Perlowin, take at least 2 years, minimum, to duplicate. “I am committed to the American farmers in producing a new clean green American Agricultural and Industrial Revolution from hemp and I’m looking forward to sharing this at the 1st Annual Ascent Expo in California.”

While North Carolina has not yet legalized hemp, the company while waiting for this to occur, will process Kenaf for the automotive, oil, textile, paper and other industries. (Kenaf, or Hibiscus cannabinus which is a plant in the Malvaceae family is a substance similar to Hemp, often called “Ambari Hemp” and “Deccan Hemp”.)

“Hemp, Inc.’s (HEMP) goal is to be the leading processor of processed and raw hemp materials when it becomes legal in North Carolina,” said Perlowin. There are also plans of building a GMP compliant facility for the extraction of CBDs from hemp. Perlowin’s migration strategy of processing Kenaf first is expected to put Hemp, Inc. years ahead in the hemp processing industry.

According to company executives, shareholders will see more of Hemp, Inc.’s core business develop. As the decortication facility in North Carolina continues to progress through the end of 2014 and through the first quarter of 2015 and on, Hemp, Inc. executives are eagerly looking forward to bringing more hemp-based clean, green solutions to the American people. “We constantly strive to deliver value to our shareholders and we believe our efforts will position us to do just that over the long term.”

The synergistic expo will put Hemp, Inc. one step further to its goal. describes the expo as “Creative Capitalism” where conscious-oriented people connect through commerce, working and living in a way that is conscious of other people, conscious of the environment and cultures, and mending those traits in everyday business practices.

To reserve a booth at the 2015 Ascent Expo in Los Angeles, California, contact Ashley Leyva at (800) 568-EXPO.


Hemp, Inc. (HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. (HEMP) is not currently involved in the cultivation or marketing of medical cannabis. ( Instead, our focus is on industrial hemp and the myriad of uses (over 25,000 products made from hemp that the hemp plant offers) in creating a new clean green American Agricultural and Industrial Revolution.

Update on Hemp, Inc.’s Decortication Plant

After months moving from its original location to its current home, the Temafa and Macintosh lineof equipment, the mill and the Kenaf is 100% completely moved to our 70,000 square-foot warehouse on seven acres purchased by Hemp, Inc. Everything is now in its new facility being assembled and organized, as Hemp, Inc. sets up shop. To see a time lapsed video on the disassembly and moving of the equipment, click here. Executives anticipate the facility to be fully operational by the end of the first quarter in 2015. The bulk of Kenaf on-hand will be processed for fiber and Lost-Circulation Material (LCMs) for the drilling industry. The final tally on the 15 million pounds of Kenaf we got for free with the purchase of the machinery is 5 million pounds as the majortiy of it was not up to our standards to be worth moving to our new facility.


The Industrial Hemp and Medical Marijuana Consulting Company (IHMMCC) is a wholly owned subsidiary of Hemp, Inc. (HEMP) that pulls industry information from a vast network of specialists. IHMMCC is entrenched in all the multi-faceted opportunities in the medical marijuana and Industrial Hemp industry. ( Executives of IHMMCC are focused on its current clients.


Hemp, Inc. (HEMP) seeks to benefit many constituencies from a “Cultural Creative” perspective thereby not exploiting or endangering any group. Thus, the publicly-traded company believes in “upstreaming” of a portion of profit from the marketing of their finished hemp goods back to its originator as an interwoven piece of nature. By Hemp, Inc. focusing on comprehensive investment results—that is, with respect to performance along the interrelated dimensions of people, planet, and profits—our triple bottom line approach can be an important tool to support sustainability goals.

About eWorld Companies, Inc.

eWorld Companies (EWRC) markets and distributes cutting edge Internet technologies including its patent-pending Boomerang Media Station(R), a multimedia content platform that delivers proprietary and third-party movies, music videos, and other streaming content via its state-of-the-art video player. eWorld also produces and promotes professional and lifestyle events through its subsidiary, “THE Xperience.”, including the upcoming 1stASCENT EXPO in Los Angeles on February 27-28 & March 1, 2015. Ascent Expo, with the byline “Commerce — Innovation — Creativity”, will provide a forum for “Cultural Creatives“, a fast-growing new breed of forward-thinking, cutting-edge businesses, individuals and non-profit organizations committed to achieving commercial and social success while applying the principles of positive psychology to people’s everyday lives and activities.

About the Ascent Expo

The 2015 Ascent Expo mission is to assemble the might of the entertainment industry, innovative corporations, moguls, influential communicators and the media to enjoy, learn, co-create successful ventures, cooperate in facilitating commerce, and empower each other toward a higher consciousness in solving our planet’s most important social, environmental and human rights issues. Ascent Expo will include multiple live music performances, eye-opening information sessions, mind-expanding motivational lessons, runway fashion shows, and red carpet celebrity excitement – with numerous television shows being filmed simultaneously throughout the event.


Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


1 1246

Nuvilex Provides Shareholder Update on Cancer and Diabetes Programs

SILVER SPRING, Md., Dec. 16, 2014 (GLOBE NEWSWIRE) — Nuvilex, Inc. (NVLX), a clinical-stage biotechnology company providing cell solutions for the treatment of diseases, today announced a shareholder update on the Company’s cancer and diabetes programs utilizing its Cell-in-a-Box(R) cellulose-based live cell encapsulation technology.

  • The first preclinical study by TD2 in the U.S. that deals with the effectiveness of Nuvilex’s pancreatic cancer treatment on the accumulation of malignant ascites fluid that is often associated with the growth of abdominal cancers, including pancreatic cancer, has been completed and positive results were obtained.
  • Nuvilex has commenced the development of a clinical protocol for the planned Phase 2b clinical trial in pancreatic cancer.
  • Applications have been submitted to drug regulatory authorities in the U.S., Europe and Australia to obtain Orphan Drug status for Nuvilex’s pancreatic cancer treatment that combines Cell-in-a-Box(R) with low doses of the anticancer prodrug ifosfamide.
  • Contracts have been executed with major institutions that will permit the development of a diabetes treatment that combines Cell-in-a-Box(R) with insulin-producing cells, and a Diabetes Consortium has been established to facilitate this important research.
  • The live cell encapsulation facility in Thailand, where the Cell-in-a-Box(R) encapsulation will be done, has now officially opened and is an extremely important development as this facility is essential for all of Nuvilex’s efforts in developing treatments for cancer and diabetes.
  • Rapid progress is being achieved at the University of Northern Colorado in the pursuit of treatments for cancer that will combine cannabinoid-like compounds with the Cell-in-a-Box(R)technology.

“This is truly an exciting, important time for Nuvilex, and I wish to extend my sincere appreciation to our longstanding shareholders for their continued support during this transformational period of our growth,” commented Kenneth L. Waggoner, Chief Executive Officer of Nuvilex.

An extensive update on Nuvilex’s programs has been prepared and can be reviewed on the Nuvilex website at:

About Nuvilex

Nuvilex (NVLX) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. Nuvilex’s treatment for pancreatic cancer involves the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form. In addition, Nuvilex is working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. Nuvilex is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. Nuvilex is examining ways to exploit the benefits of Cell-in-a-Box(R) technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides Nuvilex a unique opportunity to develop “green” approaches to fighting deadly cancers, such as those of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.

Safe Harbor

This press release may contain forward-looking statements regarding Nuvilex and its future events and results that involve inherent risks and uncertainties. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan” and similar expressions, as they relate to Nuvilex or its management, are intended to identify forward-looking statements. Important factors, many of which are beyond the control of Nuvilex, could cause actual results to differ materially from those set forth in the forward-looking statements. They include Nuvilex’s ability to continue as a going concern, delays or unsuccessful results in clinical trials or flaws or defects regarding its product candidates, changes in relevant legislation or regulatory requirements, uncertainty of protection of Nuvilex’s intellectual property and Nuvilex’s continued ability to raise capital. Nuvilex does not assume any obligation to update any of these forward-looking statements.

More information about Nuvilex can be found at It can also be obtained by contacting Investor Relations.

Investor Relations Contacts:
Clare Matschullat
Blueprint Life Science Group
Telephone: 415.375.3340 Ext. 106

1 1473

MJ Holdings, Inc. to Present at Cannabis Investor Webcast

Miami, FL, Dec. 16, 2014 (GLOBE NEWSWIRE) — MJ Holdings, Inc. (MJNE) a Florida-based public company focused on financing companies within the Marijuana industry, announced it will be presenting at the Cannabis Investor Webcast on Thursday, December 18 from 9am- 9.45am ET.

The Cannabis Investor Webcast will include presentations from publicly-traded and leading privately-held cannabis industry companies and industry professionals. MJ Holdings, Inc.’s presentation will be 30-minutes long followed by 15-minutes of Q&A. The Cannabis Investor Webcast attracts international and domestic cannabis entrepreneurs, individual and institutional investors, analysts, media and consumers, offering them an inside look of dynamic companies which are poised to expediently grow in 2015.

“This is the right time for investors to get in early as the cannabis industry has captured the imagination of the country and demonstrated its viability over the past year” said Adam Laufer, Co-Chief Executive Officer at MJ Holdings, Inc. “The Cannabis Investor Webcast’s interactive platform will assist us in increasing our liquidity, awareness, and exposure of our services while giving us an opportunity to introduce our company and senior leadership to an interested and engaged audience.”

MJ Holdings, Inc. provides real estate solutions and real estate backed financial products, including hard money loans and sale and lease back transactions to licensed operators. The Company is actively seeking licensed operators who require the right financial partner to help them expand their businesses by financing their real estate needs. In addition to Colorado, MJ Holdings, Inc. is exploring commercial real estate opportunities in states which have passed laws allowing for the cultivation and sale of marijuana.

For those unable to attend the webcast, a recording of MJ Holdings, Inc.’s presentation will be available on the Cannabis Investor Webcast YouTube page.

About MJ Holdings

MJ Holdings, Inc., a publicly traded company (MJNE), acquires and leases real estate to licensed marijuana operators, including, but not limited to, providing complete turnkey growing space and related facilities to licensed marijuana growers and dispensary owners. Additionally, MJ Holdings plans to explore ancillary opportunities in the regulated marijuana industry. For more information please visit us at

The Company does not and will not, until such time as Federal law allows, grow, harvest, distribute or sell marijuana or any substances that violate the laws of the United States of America.

Safe Harbor Statement

This press release contains certain forward-looking statements that are made pursuant to the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These forward-looking statements concern MJ Holdings’ operations, economic performance, financial condition, financial services and product offerings and are based largely on MJ Holding’s beliefs and expectations. These statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of MJ Holdings to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Certain of these factors and risks, as well as other risks and uncertainties are stated in MJ Holdings’ Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and in MJ Holdings’ subsequent filings with the U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date of this press release, and MJ Holdings assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements.

KCSA Strategic Communications
Jon Goldberg / Andrew Herweg /
212-896-1282 / 212-896-1273

1 1340

FutureWorld (FWDG) Subsidiary CB Scientific Awarded Product of the Year from the Cannabis Business Awards

CB Scientific Recognized by Peers and Voters just 94 days after Launch of Products!

ST. PETERSBURG, FL, Dec. 16, 2014 (GLOBE NEWSWIRE) — FutureWorld Corp. (OTCQB; FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announced that CB Scientific, a subsidiary of FutureWorld Corp., has received the “Product of the Year” from the Cannabis Business Awards. The Cannabis Business Awards are presented to cannabis industry businesses, individuals and organizations, in both medical and recreational sectors as well as ancillary industries. Awards go to those deserving of historical recognition and esteemed accolades.

“To win this award, just 94 days after the launch of the Test Kit products, is truly an honor”, said CEO of FutureWorld, Sam Talari. “This award further demonstrates that we are not just a technology and solutions company to the cannabis industry, but we are truly innovators in the space. We constantly strive to discover disruptive products in our sector, and this peer recognition is confirmation of our efforts.”

CB Scientific’s PersonalAnalytics are the first tests for consumers that are available for personal use to test for cannabinoids, including THC and CBD, outside of a lab setting. These affordable and high-quality tests provide results in ten minutes or less, and have numerous uses for recreational and medical purposes, including patients who need to use medical cannabis and hemp-related products such as CBD oil.

Both THC and CBD home testing kits are available at several outlets in Alaska, Michigan, California, Washington and Colorado, specifically head shops, dispensaries and grow stores. The kits are also available for purchase worldwide online at The tests have been featured on ABC, CBS, Fox, The Adam Dunn Show, as well as in publications such as High Times and Forbes Magazine.

About CB Scientific

CB Scientific ( is a wholly owned Florida company based in Denver Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis analytics. Senior management team are some of the primary men advancing gas chromatography testing in Colorado. CB Scientific believes every product sold to patients as “Medical Quality” should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.

Senior management team of CB Scientific have worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, many trade publications, on-air interviews and panel discussions across the United States. CB Scientific’s focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.

About FutureWorld Corp

FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. FutureWorld, through its subsidiaries such as HempTech and CB Scientific, provides personal and professional THC and CBD test kits, pure CBD oil solutions, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.

To request further information about FutureWorld, please email us at, log onto our website at or visit us at our Facebook page or on Twitter #futureworldinc.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Media Contact
FutureWorld Corp.


Investor Relations
(727) 474-1816 ext. 103

1 1481
marijuana stocks

Cannabis Sativa, Inc. Clarifies Its Relationship with Baked Botanicals in the Washington Cannabis Market


Cannabis Sativa, Inc. (CBDS) (referred to collectively with its subsidiaries as “CBDS”) announced today a clarification of its relationship with Green Chief LLC d/b/a Baked Botanicals, a licensed I-502 cannabis infused edible producer and processor based in Granite Falls, Washington.

In October, 2014, CBDS entered into a packaging arrangement with Baked Botanicals. In December 2014 Baked Botanicals introduced three products to market in the State of Washington which were branded with the “hi” brand shared with CBDS and packaged using the designs. Baked Botanticals agreed to pay CBDS for the packaging of the products.

CBDS is not licensed to sell and has not sold any cannabis related products in the State of Washington nor has CBDS played any role in the production or sale of Baked Botanicals’ products or the conduct of its business operations

CBDS would like to further clarify that Stesha Ries was incorrectly attributed as the owner and operator of Baked Botanicals. Stesha Ries is the Director of Operations for Baked Botanicals.

Forward-Looking Statements

This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Cannabis Sativa, Inc.
Michael Pickens
Investor Information

0 1452

NTRR: Decision to Allow Cannabis Cultivation and Sales on Indian Reservations Could Lead to More Explosive Growth in Multi-Billion-Dollar U.S. Cannabis Industry


Neutra Corp. (NTRR) and other innovators working to serve the needs of the fast-growing U.S. cannabis industry received more good news last week when the Department of Justice announced that it would allow Native American tribes to cultivate and sell cannabis on their reservations—even in states where the plant remains outlawed. It’s a move many experts believe could trigger a massive new wave of growth in an industry forecast to be worth as much as $35 billion by 2020.

“There are more than 300 reservations in 30 states across the country,” said NTRR CEO Chris Brown. “If even a small percentage of these tribal nations elect to make cannabis available on their lands, access to the medicinal herb could soon be no more than a short car trip away for broad swaths of the United States.”

“More importantly, it should become more and more difficult for the federal government to justify cannabis’ status as a Schedule 1 drug if millions of Americans can purchase it safely and responsibly at a neighborhood dispensary or a nearby reservation,” he added.

Tribes will have to follow the same federal guidelines for legalizing the plant as the four states that have already elected to do so, including preventing distribution to minors and ensuring that proceeds do not go to gangs or cartels.

NTRR is preparing for the phenomenal growth predicted to come in the U.S. cannabis industry by working to deliver innovative new products to serve the rapidly expanding marketplace. Earlier this year, NTRR acquired Diamond Anvil Designs, a cutting-edge developer of smoke-free nutraceutical delivery systems that can be adapted to deliver a variety of substances, including dry herbs, oils and waxes. The lightweight, portable vapor pen represents a major breakthrough in vaporization technology thanks to customizable power levels, multi-substance vaporization capacity and best-in-class durability.

For more information on NTRR’s initiatives, please visit

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By delivering a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), Growlife Inc. (PHOT) and Medbox Inc. (MDBX) and other leaders in the fast-growing, billion-dollar U.S. cannabis industry. For investing information and performance data, please visit

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO

1 1310

Surna Selected to Present at Investor-Focused Cannabis Investor Webcast

Boulder, CO / ACCESSWIRE / December 16, 2014 / Surna Inc. (SRNA), an engineering, manufacturing, and installation Company specializing, where state law permits, in commercial indoor cannabis cultivation technology, has been selected to participate in the Cannabis Investor Webcast on December 18, 2014, at 11:00 a.m. EST. Surna CEO Tom Bollich will speak live and detail the Company’s engineering and tech-based approach to cannabis cultivation.

“This webcast is a great opportunity for our shareholders to gain a better understanding of the technology our engineering team has developed, as well as where Surna is heading. We believe our Company and our disruptive technology are well positioned to advance the entire cannabis industry,” said Bollich. “Cannabis cultivation is becoming increasingly technical, so Surna has assembled some very ambitious engineers and put them to work under one roof. Our engineering collective is motivated, diverse and capable of creating technologies that are years ahead of their time.”

Surna’s keystone product, a water-cooled climate control system, is an energy efficient alternative to traditional HVAC. In Q1 2015, Surna will release its water-cooled reflector, which will offer up to 50% energy savings on climate control, when paired with Surna’s chiller. Behind lighting, climate control is the second largest energy cost in a grow operation.

The webcast will include presentations and Q&A sessions from Surna and nine additional private and public cannabis related companies including Viridian Capital and Research and Lexaria Corp. over the course of the day. Interested cannabis investors can register for the webcast at no charge at

About Surna, Inc.:

Surna, Inc. ( engineers, manufactures and installs commercial agricultural equipment to cannabis cultivation facilities. Surna acquires scalable operating companies in the cannabis sector and expands them by incorporating its proprietary grow technology and comprehensive support systems.

Surna is headed by technology industrialist and robotics engineer Tom Bollich, co-founder of the highly-publicized gaming Company Zynga. The Company drew national attention when its market valuation quickly surpassed $10 billion.

Surna’s nine-man engineering team sidesteps technological obsolescence by perpetually developing improved cultivation systems. This engineering advantage provides the Company with financial access to the entire cannabis economy. Surna continuously creates highly adaptive technology and software that satisfies the numerous, highly-specific and essential demands of the cannabis industry. Because cannabis remains federally illegal, Surna’s operations exclude the production or sale of marijuana. Interested parties are advised to read Surna’s Statement About Cannabis Markets below.

About Cannabis Investor Webcast:

The Cannabis Investor Webcast is held monthly on the fourth Tuesday of the month. The webcast includes 45-minute live presentations and Q&A by CEO’s and CFO’s of privately-held and publicly traded cannabis companies. The webcast audience includes international and domestic cannabis entrepreneurs, individual and institutional investors, analysts, media, and consumers. The Cannabis Investor Webcast offers cannabis companies a convenient and inexpensive way to increase liquidity, awareness and exposure. In addition, the Cannabis Investor Webcast gives cannabis entrepreneurs, individual and institutional investors, analysts, media, and consumers a convenient and inexpensive way to research privately-held and publicly traded cannabis companies.

Safe Harbor Statement

This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results, new features or services, or management strategies) and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as “may,” “should,” “expect,” “anticipate,” “believe,” “estimate,” “intend,” “plan” and other similar expressions. Our actual results, such as the Company’s ability to finance, complete and consolidate acquisition of IP, assets and operating companies, could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company such as a result of various factors, including future economic, competitive, regulatory, and market conditions. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Statement About Cannabis Markets

The use, possession, cultivation, and distribution of cannabis is prohibited by federal law. This includes medical and recreational marijuana. Although certain states have legalized medical and recreational cannabis, companies and individuals involved in the sector are still at risk of being prosecuted by federal authorities. Further, the landscape in the cannabis industry changes rapidly. What was the law last week is not the law today and what is the law today may not be the law next week. This means that at any time the city, county, or state where cannabis is permitted can change the current laws and/or the federal government can supersede those laws and take prosecutorial action. Given the uncertain legal nature of the cannabis industry, it is imperative that investors understand that the cannabis industry is a high risk investment. A change in the current laws or enforcement policy can negatively affect the status and operation of our business, require additional fees, stricter operational guidelines and unanticipated shut downs.

At the Company
David Traylor
Chief Business Officer
(303) 993-5271

Investor Relations
David Kugelman
Atlanta Capital Partners, LLC
(404) 856-9157
(866) 692-6847 Toll Free – U.S. And Canada

SOURCE: Surna Inc.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact
Ad Placements